B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression

FEBS Letters

Volumn 587, Issue 15, 2013, Pages 2385-2392

  Kee, Hae Jin ^a   Park, Sangha ^a   Kwon, Jin Sook ^a   Choe, Nakwon ^a   Ahn, Youngkeun ^a   Kook, Hyun ^a   Jeong, Myung Ho ^a  

^a Chonnam National University   (South Korea)

Author keywords

BTG3; miR 142 5p; Neointima hyperplasia; Proliferation; Vascular smooth muscle cell

Indexed keywords

MICRORNA; MICRORNA 142 5P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL TRANSLOCATION GENE; CAROTID ARTERY INJURY; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GROWTH REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA BINDING; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

BTG3; MIR-142-5P; NEOINTIMA HYPERPLASIA; PROLIFERATION; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84880697799     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.06.005     Document Type: Article

References (28)

1. A. Rudijanto The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis Acta Med. Indones. 39 2007 86 93
2. P. Lacolley, V. Regnault, A. Nicoletti, Z. Li, and J.B. Michel The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles Cardiovasc. Res. 95 2012 194 204
3. Y.H. Ou, P.H. Chung, F.F. Hsu, T.P. Sun, W.Y. Chang, and S.Y. Shieh The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1 EMBO J. 26 2007 3968 3980
4. S. Majid, A.A. Dar, A.E. Ahmad, H. Hirata, K. Kawakami, and V. Shahryari BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer Carcinogenesis 30 2009 662 670
5. L.J. Chen, S.H. Lim, Y.T. Yeh, S.C. Lien, and J.J. Chiu Roles of microRNAs in atherosclerosis and restenosis J. Biomed. Sci. 19 2012 79
6. S. Costinean, N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, and N. Heerema Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice Proc. Natl. Acad. Sci. U.S.A. 103 2006 7024 7029
7. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
8. H.W. Hwang, and J.T. Mendell MicroRNAs in cell proliferation, cell death, and tumorigenesis Br. J. Cancer 94 2006 776 780
9. M. Galasso, M.E. Sana, and S. Volinia Non-coding RNAs: a key to future personalized molecular therapy? Genome Med. 2 2010 12
10. A. Caporali, and C. Emanueli MicroRNAs in postischemic vascular repair Cardiol. Res. Pract. 2012 2012 486702
11. H.S. Soifer, J.J. Rossi, and P. Saetrom MicroRNAs in disease and potential therapeutic applications Mol. Ther. 15 2007 2070 2079
12. N.J. Leeper, A. Raiesdana, Y. Kojima, H.J. Chun, J. Azuma, and L. Maegdefessel MicroRNA-26a is a novel regulator of vascular smooth muscle cell function J. Cell. Physiol. 226 2011 1035 1043
13. D. Torella, C. Iaconetti, D. Catalucci, G.M. Ellison, A. Leone, and C.D. Waring MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo Circ. Res. 109 2011 880 893
14. K.R. Cordes, N.T. Sheehy, M.P. White, E.C. Berry, S.U. Morton, and A.N. Muth MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 460 2009 705 710
15. Y. Cheng, X. Liu, J. Yang, Y. Lin, D.Z. Xu, and Q. Lu MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation Circ. Res. 105 2009 158 166
16. Y.S. Wang, H.Y. Wang, Y.C. Liao, P.C. Tsai, K.C. Chen, and H.Y. Cheng MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation Cardiovasc. Res. 95 2012 517 526
17. R. Ji, Y. Cheng, J. Yue, J. Yang, X. Liu, and H. Chen MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation Circ. Res. 100 2007 1579 1588
18. W.H. Wu, C.P. Hu, X.P. Chen, W.F. Zhang, X.W. Li, and X.M. Xiong MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension Am. J. Hypertens. 24 2011 1087 1093
19. S.G. Sun, B. Zheng, M. Han, X.M. Fang, H.X. Li, and S.B. Miao MiR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation EMBO Rep. 12 2011 56 62
20. X. Liu, Y. Cheng, S. Zhang, Y. Lin, J. Yang, and C. Zhang A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia Circ. Res. 104 2009 476 487
21. I. Bentwich, A. Avniel, Y. Karov, R. Aharonov, S. Gilad, and O. Barad Identification of hundreds of conserved and nonconserved human microRNAs Nat. Genet. 37 2005 766 770
22. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
23. H.J. Kee, J.S. Kwon, S. Shin, Y. Ahn, M.H. Jeong, and H. Kook Trichostatin A prevents neointimal hyperplasia via activation of Kruppel like factor 4 Vascul. Pharmacol. 55 2011 127 134
24. F. Guehenneux, L. Duret, M.B. Callanan, R. Bouhas, S. Hayette, and C. Berthet Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle Leukemia 11 1997 370 375
25. Y. Saito, H. Suzuki, H. Tsugawa, H. Imaeda, J. Matsuzaki, and K. Hirata Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication PLoS One 7 2012 e47396
26. X. Zhang, Z. Yan, J. Zhang, L. Gong, W. Li, and J. Cui Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection Ann. Oncol. 22 2011 2257 2266
27. S. Yanagida, K. Taniue, H. Sugimasa, E. Nasu, Y. Takeda, and M. Kobayashi ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma Sci. Rep. 3 2013 1305
28. R. Vernell, K. Helin, and H. Muller Identification of target genes of the p16INK4A-pRB-E2F pathway J. Biol. Chem. 278 2003 46124 46137